Mark J Arends Selected Research

Mark J Arends Research Topics

Disease

27	Neoplasms (Cancer) 12/2021 - 07/2002
13	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 10/2003
12	Adenoma (Adenomas) 04/2022 - 10/2003
5	Melanoma (Melanoma, Malignant) 11/2021 - 02/2015
5	Carcinogenesis 10/2016 - 09/2002
4	Microsatellite Instability 01/2020 - 01/2010
4	Hyperplasia 01/2017 - 10/2006
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 12/2021 - 10/2018
3	Adenocarcinoma 12/2021 - 10/2003
3	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2009
2	Insulin Resistance 01/2019 - 07/2017
2	Carcinoma (Carcinomatosis) 01/2018 - 06/2013
2	T-Cell Lymphoma (Lymphoma, T Cell) 10/2016 - 10/2009
2	Genomic Instability 10/2016 - 09/2002
2	Infections 01/2016 - 10/2014
2	Anemia 01/2015 - 12/2014
2	Bone Marrow Failure Disorders 09/2012 - 07/2011
2	Chromosomal Instability (Chromosome Stability) 02/2011 - 09/2002
2	Atherosclerosis 10/2004 - 10/2003
1	Polyps 04/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Essential Osteolysis 01/2022
1	Weight Loss (Weight Reduction) 12/2021
1	Cachexia 12/2021
1	Cockayne Syndrome (Syndrome, Cockayne) 12/2021
1	Renal Insufficiency (Renal Failure) 12/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Acrospiroma 01/2019
1	Male Infertility (Male Sterility) 01/2019
1	Nevus (Nevi) 01/2019
1	Granuloma 11/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2017
1	Hypertension (High Blood Pressure) 07/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2017
1	Type 2 Diabetes Mellitus (MODY) 07/2017
1	Endometrial Hyperplasia 01/2017
1	Alopecia (Baldness) 01/2016
1	Thymoma (Thymic Carcinoma) 02/2015
1	Jervell-Lange Nielsen Syndrome (Jervell and Lange-Nielsen Syndrome) 12/2014
1	Dysbiosis 10/2014
1	Colitis 10/2014

Drug/Important Bio-Agent (IBA)

12	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2007
8	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2007
6	Calcibiotic Root Canal SealerIBA 04/2022 - 07/2010
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2015
4	CarcinogensIBA 01/2017 - 04/2010
4	Protein Isoforms (Isoforms)IBA 07/2011 - 01/2006
3	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2006
3	Ethanol (Ethyl Alcohol)IBA 12/2021 - 07/2011
3	Phosphotransferases (Kinase)IBA 11/2021 - 02/2014
3	Dimenhydrinate (DMH)FDA LinkGeneric 02/2014 - 04/2010
2	A-Form DNA (A-DNA)IBA 12/2021 - 02/2010
2	AntibodiesIBA 12/2017 - 10/2003
2	IronIBA 01/2015 - 12/2014
2	Potassium Channels (Potassium Channel)IBA 01/2015 - 12/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2011 - 10/2009
2	GastrinsIBA 07/2011 - 10/2009
2	Codon (Codons)IBA 03/2011 - 03/2010
2	oxidized low density lipoproteinIBA 10/2004 - 10/2003
1	Appetite Depressants (Anorectics)IBA 12/2021
1	Formaldehyde (Formol)FDA Link 12/2021
1	S100 Proteins (S 100 Protein)IBA 11/2021
1	MART-1 AntigenIBA 11/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2019
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	Galectin 3 (LGALS3)IBA 11/2018
1	EpitopesIBA 10/2018
1	1-dodecylpyridoxal (PLD)IBA 01/2018
1	liposomal doxorubicin (Doxil)FDA Link 01/2018
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 07/2017
1	Triglycerides (Triacylglycerol)IBA 07/2017
1	Complement Factor B (Factor B)IBA 07/2017
1	MTOR InhibitorsIBA 03/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2017
1	condensin complexes (condensin)IBA 10/2016
1	DNA Polymerase IIIBA 08/2016
1	Intrinsic Factor FDA Link 01/2016
1	VitaminsIBA 01/2016
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2016
1	CeramidesIBA 01/2016
1	PLX 4720IBA 02/2015
1	MK 2206IBA 02/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 02/2015
1	ABT-737IBA 02/2015
1	Biological ProductsIBA 11/2014
1	interleukin-22 receptor (IL-22R)IBA 10/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2014
1	Mitogen-Activated Protein KinasesIBA 02/2014

Therapy/Procedure

3	Immunotherapy 01/2020 - 10/2018
2	Therapeutics 10/2018 - 04/2009
1	Drug Therapy (Chemotherapy) 12/2021